Health and Human Services Secretary Alex Azar today named as his senior advisor for drug pricing reform John O’Brien, a pharmacist who previously served as deputy assistant secretary for health policy and an advisor on health reform and drug pricing. He replaces Daniel Best, who died last month. “John O’Brien has already been an integral leader in HHS’s efforts to bring down the high price of prescription drugs,” Azar said. “As a senior advisor, he will carry forward the legacy of our departed colleague Dan Best and build on the substantial progress that has already been made.” Before joining HHS, O’Brien was vice president of public policy for CareFirst BlueCross BlueShield.

Related News Articles

Headline
Brad Smith, former chief operating officer for Anthem’s Diversified Business Group, will serve as director of the Center for Medicare & Medicaid Innovation…
Headline
The Senate today voted 72-18 to confirm Stephen Hahn, M.D., as Food and Drug Administration commissioner. Hahn currently serves as chief medical executive and…
Headline
The Senate Health, Education, Labor and Pensions Committee today voted 18-5 to approve President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and…
Headline
Thomas Engels was promoted this month to administrator of the Health Resources and Services Administration after serving as acting administrator since August.…
Headline
The Senate Health, Education, Labor and Pensions Committee today held a hearing on President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and…
Headline
President Trump today announced his intention to nominate Stephen Hahn, M.D., to lead the Food and Drug Administration. Ned Sharpless, M.D., has been serving…